Nomura Asset Management CO LTD Immunocore Holdings PLC Transaction History

Nomura Asset Management CO LTD

  • $32.3 Billion
  • Q4 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$60.14 - $75.36 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$42.85 - $69.5 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$49.5 - $66.6 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$48.54 - $61.64 $0 - $0
0 New
0 $0
Q1 2023

Jan 10, 2025
BUY
$46.12 - $65.71 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$46.12 - $65.71 $0 - $0
0 New
0 $0
Q4 2022

Jan 10, 2025
BUY
$45.51 - $65.08 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023
BUY
$45.51 - $65.08 $0 - $0
0 New
0 $0

Others Institutions Holding IMCR

# of Institutions
125
Shares Held
42.5M
Call Options Held
79.9K
Put Options Held
46.2K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.31B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email